NCT01017978

Quantitative MR Biomarkers for Sarcoma Treatment

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 11 (actual)
• Sponsor: University of Michigan · Academic / Other
• Sex: All
• Age: 3 Years
• Healthy volunteers: Not accepted

Summary

To determine if MRI imaging can be used to accurately determine if a sarcoma is responding to the type of chemotherapy being used.

Detailed description

The purpose of this study is to determine if MRI imaging can be used to accurately determine if a sarcoma is responding to the type of chemotherapy being used or if it is ineffective early on in the treatment; instead of finding this out 2-3 months later. If it is determined that MRI can accurately diagnose tumor response, medications can be switched early on potentially improv8ing the patients'chances of recovery.

Conditions

• Soft Tissue Tumors

Interventions

Type	Name	Description
PROCEDURE	MRI Scan of soft tissue tumor	MRI scan will be completed at baseline (prior to start of subject's clinically ordered chemotherapy treatments.

Timeline

• Start date: 2009-07-01
• Primary completion: 2011-12-01
• Completion: 2012-04-01
• First posted: 2009-11-23
• Last updated: 2015-12-04

Locations

1 site across 1 country: United States